Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Change in Acquisitions & Divestments (2021 - 2025)

Historic Change in Acquisitions & Divestments for Strata Critical Medical (SRTAW) over the last 5 years, with Q3 2025 value amounting to $51.7 million.

  • Strata Critical Medical's Change in Acquisitions & Divestments fell 2071.77% to $51.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $212.5 million, marking a year-over-year increase of 2652.58%. This contributed to the annual value of $177.4 million for FY2024, which is 3292.05% down from last year.
  • Latest data reveals that Strata Critical Medical reported Change in Acquisitions & Divestments of $51.7 million as of Q3 2025, which was down 2071.77% from $43.6 million recorded in Q2 2025.
  • Strata Critical Medical's 5-year Change in Acquisitions & Divestments high stood at $208.7 million for Q2 2022, and its period low was $9.5 million during Q4 2024.
  • For the 5-year period, Strata Critical Medical's Change in Acquisitions & Divestments averaged around $74.4 million, with its median value being $58.5 million (2024).
  • Per our database at Business Quant, Strata Critical Medical's Change in Acquisitions & Divestments skyrocketed by 102135.23% in 2023 and then crashed by 5109.86% in 2024.
  • Quarter analysis of 5 years shows Strata Critical Medical's Change in Acquisitions & Divestments stood at $17.2 million in 2021, then tumbled by 41.89% to $10.0 million in 2022, then skyrocketed by 1233.5% to $133.4 million in 2023, then tumbled by 92.88% to $9.5 million in 2024, then skyrocketed by 444.21% to $51.7 million in 2025.
  • Its Change in Acquisitions & Divestments was $51.7 million in Q3 2025, compared to $43.6 million in Q2 2025 and $107.8 million in Q1 2025.